![Samjin Pharmaceuticals Co., Ltd. logo](/logos/005500.KS.webp)
Samjin Pharmaceuticals Co., Ltd.
KRX:005500.KS
Overview | Financials
Company Name | Samjin Pharmaceuticals Co., Ltd. |
Symbol | 005500.KS |
Currency | KRW |
Price | 17,910 |
Market Cap | 224,365,375,800 |
Dividend Yield | 4.04% |
52-week-range | 17,110 - 24,400 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Yong-Joo Choi |
Website | https://www.samjinpharm.co.kr |
An error occurred while fetching data.
About Samjin Pharmaceuticals Co., Ltd.
Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD